Early T cell activation correlates with expression of apoptosis markers in patients with end-stage renal disease.

Détails

ID Serval
serval:BIB_23330
Type
Article: article d'un périodique ou d'un magazine.
Collection
Publications
Institution
Titre
Early T cell activation correlates with expression of apoptosis markers in patients with end-stage renal disease.
Périodique
Journal of the American Society of Nephrology : Jasn
Auteur⸱e⸱s
Meier P., Dayer E., Blanc E., Wauters J.P.
ISSN
1046-6673 (Print)
ISSN-L
1046-6673
Statut éditorial
Publié
Date de publication
2002
Volume
13
Numéro
1
Pages
204-212
Langue
anglais
Notes
Publication types: Journal Article ; Research Support, Non-U.S. Gov't
Publication Status: ppublish
Résumé
ABSTRACT. End-stage renal failure (ESRF) and chronic hemodialysis (HD) induce a state of immunodeficiency that involves T cell-mediated responses. A decreased T cell number combined with a reduced T cell lifespan and an increased T cell activation might play a role in the immune impairment associated with ESRF and chronic HD. Increased T cell activation associated with immunodeficiency suggests that activated T cells may be driven to apoptosis. To test this hypothesis, CD3+ T cell activation (CD69) and apoptosis (annexin V, CD95 (Fas), and DNA fragmentation) were analyzed in a case control study after blood draw sampling (ex vivo), in culture conditions, and after phytohemagglutinin or anti-CD3 stimulation. Ex vivo evaluation of T cells showed an increased number of activated CD69+ T cells in chronic HD patients (142 +/- 5 cells/mm3) compared with patients with ESRF (115 +/- 2 cells/mm3, P = 0.04) and controls (74 +/- 2 cells/mm3, P = 0.0006). These data were confirmed in culture conditions and after stimulation. Similarly, annexin V and CD95 (Fas)-positive T cells were more numerous in both patient groups than in controls, irrespective of the experimental conditions (P < or = 0.005 for both markers), and their percentage was always significantly higher in chronic HD patients than in patients with ESRF. The amount of DNA fragmentation was also significantly higher in the cultured resting T cells of chronic HD patients (37 +/- 3%) than in those of patients with ESRF (25 +/- 3%) and controls (20 +/- 2%) (P = 0.01). Percentage of cultured resting T cells expressing both CD69 and annexin V markers was higher in chronic HD patients (17 +/- 4%) than in patients with ESRF (10 +/- 4%) and controls (6 +/- 2%), (P = 0.005). After stimulation (phytohemagglutinin or anti-CD3), CD69+ T cell apoptosis increased by 2.4-fold in chronic HD patients compared with 1.8-fold in patients with ESRF and only 1.2-fold in controls (P = 0.001). T cells from chronic HD patients and patients with ESRF thus showed an aberrant state of early activation that contrasted with an increased proportion of annexin V and CD95 (Fas)-positive T cells engaged in apoptosis, as confirmed by DNA fragmentation. Increased susceptibility to early activated T cell apoptosis is not only associated with uremia, but is also enhanced by HD procedure. This may account for the T lymphopenia, progressive immunodeficiency, and increased infection risk seen in these patients.
Mots-clé
Annexin A5/metabolism, Antigens, CD/metabolism, Antigens, CD95/metabolism, Antigens, Differentiation, T-Lymphocyte/metabolism, Apoptosis/physiology, Biological Markers, Case-Control Studies, Female, Humans, Kidney Failure, Chronic/blood, Kidney Failure, Chronic/physiopathology, Lectins, C-Type, Leukocyte Count, Male, Middle Aged, Renal Dialysis, T-Lymphocytes/physiology, Time Factors
Pubmed
Web of science
Création de la notice
19/11/2007 13:18
Dernière modification de la notice
20/08/2019 14:00
Données d'usage